Virtus Biotech ETF (BBP) is a publicly traded the market company. As of May 21, 2026, BBP trades at $90.21 with a market cap of $0 and a P/E ratio of 0.00. BBP moved +3.43% today. Year to date, BBP is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces BBP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own BBP include Citadel Advisors. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Virtus Biotech ETF.
| Metric | Value |
|---|---|
| Price | $90.21 |
| Market Cap | $0 |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $0.00 |
| 52-Week Low | $0.00 |
| Volume | 140.02K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
BBP analyst coverage data. Average price target: $0.00.